5HU-14179-07864

3 vaccinations 6 coded responses 23 check-ins 6 free-text entries 2 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 175 / PA
Registered: 2020-12-27

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-27
Registered in v-safe
2020-12-27
Dose 1 — Pfizer-BioNTech
2020-12-27
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea

Adult check-in
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea

Adult check-in
2020-12-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-02
Survey response — days 1–6 daily, dose 1
MedDRA: Rhinorrhoea — Feeling: Fair · Fever · Chills, Headache

Free text: Runny nose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-03
Survey response — day 7, dose 1
MedDRA: Rhinorrhoea — Feeling: Fair · Fever · Chills, Headache

Free text: Runny nose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-20
Dose 2 — Pfizer-BioNTech
2021-01-21
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-22
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work

Adult check-in
2021-01-24
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-25
Survey response — days 1–6 daily, dose 2
MedDRA: Feeling abnormal — Feeling: Fair · Site: Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work

Free text: Brain fog

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness

Adult check-in
2021-01-30
Health check-in — day 7, dose 2
Feeling: Fair · Headache

Adult check-in
2021-04-22
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-21
Survey response — 6 months, dose 2
MedDRA: Migraine, Paranasal sinus discomfort, Sinus pain — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Sinus pain and pressure with migraines

MedDRA releases: 2024-11 · check-in free text available
2021-07-21
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-27
Call 1 — Could Not Reach Participant
2021-07-30
Call 2 — Could Not Reach Participant
2021-12-08
Dose 3 — Pfizer-BioNTech
2021-12-09
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-10
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-24
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-29
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-07
Survey response — day 28, dose 3
MedDRA: Influenza B virus test positive, SARS-CoV-2 test — Feeling: Poor · Be unable to work or attend school

Free text: Tested positive for flu b with a pending covid test.

MedDRA releases: 2024-11 · check-in free text available
2022-12-08
Survey response — 12 months, dose 3
MedDRA: COVID-19, Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Flu a and COVID

MedDRA releases: 2024-11 · check-in free text available
2022-12-08
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-12-09
Call 3 — Left Voicemail
2022-12-09
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-27	Pfizer-BioNTech
2	2021-01-20	Pfizer-BioNTech
3	2021-12-08	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-07-21	Unsuccessful
2022-12-08	Unsuccessful

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-02

Systemic reaction (other): Runny nose

Release 1 — day 7, dose 1

2021-01-03

Systemic reaction (other): Runny nose

Release 2 — days 1–6 daily, dose 2

2021-01-25

Systemic reaction (other): Brain fog

Release 9 — 6 months, dose 2

2021-07-21

Symptoms: Sinus pain and pressure with migraines

Release 10 — day 28, dose 3

2022-01-07

Symptoms: Tested positive for flu b with a pending covid test.

Release 12 — 12 months, dose 3

2022-12-08

Symptoms: Flu a and COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Influenza	·	·	✓
SD	Influenza B virus test positive	·	·	✓
SD	Migraine	·	·	✓
SD	Paranasal sinus discomfort	·	·	✓
SD	SARS-CoV-2 test	·	·	✓
SD	Sinus pain	·	·	✓
SRO	Feeling abnormal	✓	✓	✓
SRO	Rhinorrhoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release